DYRK1A and ovarian carcinoma: Moreover, this kinase mediates the DREAM complex assembly (Table 1) leading to ovarian cancer dormancy as DYRK1A inhibition reduced spheroid viability and restored sensitivity to chemotherapy and targeting actively proliferating cells [53].